Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 28, 2026

Sep. 28, 2026

Aurora Mobile Showcases at Tourism EXPO Japan 2026: How AI is Solving the Travel Industry’s Staffing Crisis

Indeterminate GlobeNewswire

Sep. 28, 2026

Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke

Indeterminate GlobeNewswire

Sep. 28, 2026

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Indeterminate GlobeNewswire

Sep. 28, 2026

Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

Indeterminate GlobeNewswire

Sep. 28, 2026

VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations

Indeterminate GlobeNewswire

Sep. 28, 2026

Troilus Receives US$850 Million Credit-Approved Debt Commitment Letter for the Troilus Gold-Copper Project

Indeterminate GlobeNewswire

Sep. 28, 2026

BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team

Indeterminate GlobeNewswire

Sep. 28, 2026

Troilus reçoit une lettre d’engagement de financement par emprunt de 850 M$ US ayant obtenu l’approbation de crédit pour le projet or-cuivre Troilus

Indeterminate GlobeNewswire

Sep. 28, 2026

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

GoldInxs Mining Corp. Announces $1,150,000 Private Placement Offering

Indeterminate GlobeNewswire

Sep. 28, 2026

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Indeterminate GlobeNewswire

Sep. 28, 2026

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase

Indeterminate GlobeNewswire

Sep. 28, 2026

Armlogi Holding Corp. Reports Fiscal Year 2026 Financial Results; Warehousing Services Revenue Grows 21.9% to $77.1 Million

Indeterminate GlobeNewswire

Sep. 28, 2026

Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab

Indeterminate GlobeNewswire

Sep. 28, 2026

Online Trading Trends Every New Trader in Europe Should Know In 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

Green Data Centers and the New Mexico Building and Construction Trades Council Partner to Set a New Standard for Responsible Data Center Development in New Mexico

Indeterminate GlobeNewswire

Sep. 28, 2026

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

Indeterminate GlobeNewswire

Sep. 28, 2026

Affiliate of Jefferson Energy Companies Agrees to Acquire Crude Oil Logistics Assets from USD Group

Indeterminate GlobeNewswire

Sep. 28, 2026

NOTICE TO DISREGARD -- Direct Meds

Indeterminate GlobeNewswire